- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03908190
Personalized Support for Progress (PSP) in a VA Women's Wellness Clinic
March 15, 2021 updated by: Emily M. Johnson, Syracuse VA Medical Center
Pilot Trial of Personalized Support for Progress (PSP) in a VA Women's Wellness Clinic
The purpose of this study is to evaluate the Personalized Support for Progress (PSP) intervention in a Veterans Health Administration (VHA) Women's Wellness Clinic.
PSP uses a peer support provider to help women identify their primary concern, develop a personalized plan to help address that concern, and provide practical and emotional support to implement the plan.
The primary aim is to evaluate the feasibility, acceptability, and utility of PSP and the research protocol.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
28
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
Syracuse, New York, United States, 13210
- Syracuse VA Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Veteran status (non-Veterans will not be enrolled in this trial)
- Enrollment in the Syracuse VA Medical Center Women's Wellness Clinic
- Report high stress within the last month (Perceived Stress Scale [PSS-10] > 18)
- Primary Care Provider approval for participation
- Ability to communicate in English including reading, writing, hearing, and speaking well enough to complete research and intervention tasks.
Exclusion Criteria:
- Any Veteran with "higher" suicide risk on the P4 or Veterans with "lower" suicide risk on the P4 and evaluated by the PI or another clinician to be clinically unstable or at risk
- Homicidality (screened via adaptation of the P4 screener and evaluated on the same criteria above)
- Homelessness (including literally homeless, imminent risk of homelessness, or fleeing/attempting to flee domestic violence per VA definitions)
- Veterans who are enrolled in or have had psychotherapy or changes to psychotropic medications in the last 12 weeks
- Veterans with impairment that would not allow them to engage in PSP including active psychosis, cognitive deficits, severe substance use requiring detoxification (documented in CPRS or reported by a PACT member)
- Veterans who are not available for outpatient PSP meetings (e.g., in a residential program)
- Veterans who have current VA or non-VA peer support engagement (an appointment within the last month and/or additional follow-up scheduled)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Treatment As Usual
Participants will receive treatment as usual within the VHA Women's Wellness Clinic including any appropriate treatment or treatments for their medical and psychosocial concerns as determined by their primary care teams.
|
|
Experimental: Treatment As Usual Plus Personalized Support for Progress
In addition to treatment as usual, women will receive the Personalized Support for Progress intervention.
|
Participants will receive the Personalized Support for Progress Intervention from a peer support provider including sessions with the peer support provider to complete a prioritization task, develop a personalized care plan, and receive support for implementing the personalized care plan.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Assessment Retention Rate
Time Frame: 6 months
|
This is an assessment of trial feasibility.
|
6 months
|
Intervention Retention Rate
Time Frame: 6 months
|
This is an assessment of trial feasibility.
|
6 months
|
Client Satisfaction Questionnaire
Time Frame: 6 months
|
This scale measures satisfaction and ranges from 8-24 with higher scores indicating higher satisfaction.
|
6 months
|
Goal Attainment Scaling
Time Frame: 6 months
|
This interview assesses progress toward individualized goals on a -2 to 2 scale with higher scores indicating more progress toward goals.
|
6 months
|
Perceived Stress Scale (PSS-10)
Time Frame: 6 months
|
This scale evaluates perceived stress and ranges from 0-40 with lower scores indicating lower levels of perceived stress.
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 13, 2019
Primary Completion (Actual)
November 16, 2020
Study Completion (Actual)
March 3, 2021
Study Registration Dates
First Submitted
October 24, 2018
First Submitted That Met QC Criteria
April 5, 2019
First Posted (Actual)
April 9, 2019
Study Record Updates
Last Update Posted (Actual)
March 16, 2021
Last Update Submitted That Met QC Criteria
March 15, 2021
Last Verified
March 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1297981
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Emotional Stress
-
Lawson Health Research InstituteWestern UniversityCompleted
-
Prof. dr. Filip RaesCompleted
-
Stanford UniversityCompletedStress, EmotionalUnited States
-
Hospital Israelita Albert EinsteinCompletedEmotional StressBrazil
-
University of SussexCompleted
-
Boston Medical CenterCompletedStress, EmotionalUnited States
-
Lawson Health Research InstituteRecruiting
-
The University of Texas Health Science Center,...National Center for Complementary and Integrative Health (NCCIH)Active, not recruiting
-
Babes-Bolyai UniversityCompletedEmotional StressRomania
-
University of California, San FranciscoCompleted
Clinical Trials on Personalized Support for Progress
-
Syracuse VA Medical CenterUS Department of Veterans AffairsActive, not recruitingDepression | PTSD | Anxiety | Psychological DistressUnited States
-
University of RochesterCompletedDepression | Quality of Life | Domestic ViolenceUnited States
-
University of South CarolinaUniversity of Vermont; University of TennesseeCompleted
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)Not yet recruitingStage IV Lung Cancer | Stage III Lung Cancer | Stage II Lung Cancer
-
Washington State UniversityUnited States Department of DefenseRecruitingMild Cognitive Impairment | Subjective Cognitive ComplaintsUnited States
-
University Hospital, LilleNational Cancer Institute, France; Centre Oscar Lambret; University of Lille...TerminatedTumor | Oncologic DisordersFrance
-
University of California, DavisEnrolling by invitationType 1 DiabetesUnited States
-
University of TorontoActive, not recruiting
-
The University of Hong KongRecruitingCancer | LungHong Kong
-
Chinese University of Hong KongCompleted